These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

552 related articles for article (PubMed ID: 29605414)

  • 21. Successful therapy of Clostridium difficile infection with fecal microbiota transplantation.
    Konturek PC; Koziel J; Dieterich W; Haziri D; Wirtz S; Glowczyk I; Konturek K; Neurath MF; Zopf Y
    J Physiol Pharmacol; 2016 Dec; 67(6):859-866. PubMed ID: 28195066
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endoscopic Delivery of Fecal Biotherapy in Inflammatory Bowel Disease.
    Kerman DH
    Gastrointest Endosc Clin N Am; 2016 Oct; 26(4):707-17. PubMed ID: 27633598
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fecal microbiota transplantation for gastrointestinal disorders.
    Malikowski T; Khanna S; Pardi DS
    Curr Opin Gastroenterol; 2017 Jan; 33(1):8-13. PubMed ID: 28134687
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outcomes of Fecal Microbiota Transplantation for Clostridium difficile Infection in Patients with Inflammatory Bowel Disease.
    Meighani A; Hart BR; Bourgi K; Miller N; John A; Ramesh M
    Dig Dis Sci; 2017 Oct; 62(10):2870-2875. PubMed ID: 28451916
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Practical Method for Preparation of Fecal Microbiota Transplantation.
    Perez E; Lee CH; Petrof EO
    Methods Mol Biol; 2016; 1476():259-67. PubMed ID: 27507347
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recurrent Clostridium difficile infection and the microbiome.
    Almeida R; Gerbaba T; Petrof EO
    J Gastroenterol; 2016 Jan; 51(1):1-10. PubMed ID: 26153514
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of recurrent Clostridium difficile infection using fecal microbiota transplantation in patients with inflammatory bowel disease.
    Newman KM; Rank KM; Vaughn BP; Khoruts A
    Gut Microbes; 2017 May; 8(3):303-309. PubMed ID: 28102756
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fecal Microbiota Transplantation in Inflammatory Bowel Disease.
    Reinisch W
    Dig Dis; 2017; 35(1-2):123-126. PubMed ID: 28147375
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fecal transplantation as a treatment for Clostridium difficile infection in patients with ulcerative colitis.
    Izquierdo Romero M; Varela Trastoy P; Mancebo Mata A
    Rev Esp Enferm Dig; 2017 Sep; 109(9):670. PubMed ID: 28747056
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Are There Potential Applications of Fecal Microbiota Transplantation beyond Intestinal Disorders?
    Zhou Y; Xu H; Huang H; Li Y; Chen H; He J; Du Y; Chen Y; Zhou Y; Nie Y
    Biomed Res Int; 2019; 2019():3469754. PubMed ID: 31467881
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Microbiota transplantation: concept, methodology and strategy for its modernization.
    Zhang F; Cui B; He X; Nie Y; Wu K; Fan D;
    Protein Cell; 2018 May; 9(5):462-473. PubMed ID: 29691757
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Donor Species Richness Determines Faecal Microbiota Transplantation Success in Inflammatory Bowel Disease.
    Vermeire S; Joossens M; Verbeke K; Wang J; Machiels K; Sabino J; Ferrante M; Van Assche G; Rutgeerts P; Raes J
    J Crohns Colitis; 2016 Apr; 10(4):387-94. PubMed ID: 26519463
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic modulation of gut microbiota in inflammatory bowel disease: More questions to be answered.
    Qiao YQ; Cai CW; Ran ZH
    J Dig Dis; 2016 Dec; 17(12):800-810. PubMed ID: 27743467
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epidemiology, Diagnosis, and Management of Clostridium difficile Infection in Patients with Inflammatory Bowel Disease.
    Rao K; Higgins PD
    Inflamm Bowel Dis; 2016 Jul; 22(7):1744-54. PubMed ID: 27120571
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Microbiota and inflammatory bowel disease: an update.].
    De Sire R; Talocco C; Petito V; Lopetuso LR; Graziani C; Gasbarrini A; Scaldaferri F
    Recenti Prog Med; 2018 Dec; 109(12):570-573. PubMed ID: 30667386
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fecal microbiota transplantation for the treatment of patients with ulcerative colitis and other gastrointestinal conditions beyond Clostridium difficile infection: an update.
    Holleran G; Scaldaferri F; Ianiro G; Lopetuso L; Mc Namara D; Mele MC; Gasbarrini A; Cammarota G
    Drugs Today (Barc); 2018 Feb; 54(2):123-136. PubMed ID: 29637938
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modulation of microbiota as treatment for intestinal inflammatory disorders: An uptodate.
    Gallo A; Passaro G; Gasbarrini A; Landolfi R; Montalto M
    World J Gastroenterol; 2016 Aug; 22(32):7186-202. PubMed ID: 27621567
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An overview of fecal microbiota transplantation: techniques, indications, and outcomes.
    Brandt LJ; Aroniadis OC
    Gastrointest Endosc; 2013 Aug; 78(2):240-9. PubMed ID: 23642791
    [No Abstract]   [Full Text] [Related]  

  • 39. Fecal microbiota transplant, its usefulness beyond Clostridioides difficile in gastrointestinal diseases.
    Núñez F P; Quera R; Bay C; Thomson P
    Gastroenterol Hepatol; 2022 Mar; 45(3):223-230. PubMed ID: 34118321
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fecal Microbiota Transplantation.
    Vindigni SM; Surawicz CM
    Gastroenterol Clin North Am; 2017 Mar; 46(1):171-185. PubMed ID: 28164849
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.